PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
CMS Issued Coverage Guidance on GLP-1 Anti-Obesity Drugs Requiring Considerations for Health Plans GLP-1s (glucagon-like peptide 1 agonist) came up in the news again after…
PBM Alternative Pricing Models Require Thoughtful Consideration For Plan Sponsors PBM alternative pricing models are being rolled out by some of the biggest organizations in…
Your Definitive Guide to Ensuring Peak Performance of Your Pharmacy Program Managing the pharmacy program has never been more complex for plan sponsors. Innovative drugs…
In the complex landscape of healthcare, the escalating costs of drugs have become a pressing concern. To learn more about how pharmacy managed care is…
